Navigation Links
Bypass Beats Stents for Diabetic Heart Patients: Study
Date:11/5/2012

By E.J. Mundell
HealthDay Reporter

MONDAY, Nov. 5 (HealthDay News) -- For a subset of heart patients who are both diabetic and have more than one clogged artery, bypass surgery appears to outperform the use of artery-widening stents, a major new trial finds.

The study adds more evidence that bypass is the preferred approach for this type of patient, according to experts discussing the findings Sunday at the annual meeting of the American Heart Association in Los Angeles.

"This has the potential to change clinical practice," said Dr. Alice Jacobs, director of the Cardiac Catheterization Laboratory and interventional cardiology at Boston Medical Center. In her commentary, she said the results of the new trial "add to the consistent evidence base supporting coronary artery bypass grafting as the preferred strategy for patients with diabetes and multi-vessel coronary heart disease."

The findings were also published online Nov. 4 in the New England Journal of Medicine.

In bypass surgeries, doctors reroute blood flow around a blocked artery using a grafted vessel taken from another part of the body. In stenting, doctors use a catheter to insert a thin metal mesh tube called a stent into the artery, to prop it open.

Bypass has typically outperformed stenting in trials done in the past, but some experts thought that was only because older stents tended to re-close too often. Over the past decade, new drug-eluting stents have been developed that work better at preventing vessel reclosure.

According to Jacobs, the new trial's launch "was fueled by the contention that drug-eluting stents would negate the advances of [bypass]."

But the trial, funded by the U.S. National Heart, Lung, and Blood Institute, found that even with the use of drug-eluting stents, bypass still came out on top -- at least for very sick, diabetic heart patients.

The study included 1,900 such patients, 83 percent
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Cardiac bypass surgery superior to non-surgical procedure for adults with diabetes and heart disease
2. Stroke Risk Higher After Bypass Than Angioplasty: Analysis
3. Less Invasive Surgery Safe for Harvesting Bypass Veins: Study
4. Lab-Grown Blood Vessels May Improve Heart Bypass
5. Moveable Magnets Used to Forge Gastric Bypass in Pigs
6. HPV Test Beats Pap Long-Term: Study
7. Medicare Beats Private Plans for Patient Satisfaction: Survey
8. Early use of stents better than medical therapy alone for certain patients
9. Expensive, Drug-Emitting Stents May Be Overused: Study
10. Dissolvable Heart Artery Stents Appear Safe in Study
11. Drug offers new pain management therapy for diabetics
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Bypass Beats Stents for Diabetic Heart Patients: Study
(Date:9/2/2015)... Norcross, GA (PRWEB) , ... September 02, 2015 ... ... Aflac Cancer Center at Children's Healthcare of Atlanta to help support ... C.H.O.A. to discuss the upcoming WSB Radio Care-A-Thon , which is the ...
(Date:9/2/2015)... ... September 02, 2015 , ... Ericson is a noted speaker and ... HCPro and Associate Director of Education for the Association for Clinical Documentation Improvement Specialists ... for CDI Boot Camps. She serves as a CDI subject matter expert for a ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... largest and fastest-growing interim clinical staffing companies, has completed a recapitalization with ... , BPOC and Heritage Group each offer extensive expertise and ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... is taking action after seeing a significant increase in unlawful tactics used ... division has found many cases of OON ASCs encouraging members to have elective ...
(Date:9/2/2015)... , ... September 02, 2015 , ... Every year at ... others dread it. However, few are prepared to face the academic workload confronting them. ... Our schools haven’t prepared them since schools don’t teach students how to study. , ...
Breaking Medicine News(10 mins):Health News:DoMyOwnPestControl.com Goes Gold for Childhood Cancer Awareness Month 2Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 2Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 3Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 4Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 3Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 4Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 3Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 2Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 3
... of Queensland believe that the conotoxins present in the ... from chronic pain//. This treatment could replace the conventional ... say that the toxin, snail uses to hunt its ... effects usually caused by other pain treatments. ...
... easily available to critically ill patients. The Food and Drug ... who are extremely ill to try out experimental drugs when ... FDA has announced that they will consider the prices that ... to needy individuals .They will also clarify the norms and ...
... by researchers from University of Sydney suggested that having ... problems in breastfeeding//. The study results were published in ... ,Researchers, who studied 1,300 women who gave birth ... have the anaesthetic are more likely to have problems ...
... for the American public. A decade after genetically altered ... remain ignorant and disinclined towards them. ,According to ... and Biotechnology, the last five years have seen little ... ,Says executive director of the survey’s sponsor, Michael ...
... conducted at the Auckland Aquatic Center in Henderson. //Six 12 ... at the West Wave Aquatic Centre on Dec 10. The ... be admitted in the hospital. ,Waitakere City Council ... concerned by what had occurred and investigations are continuing into ...
... effective as popular sports drinks and gels in maintaining ... endurance athletes who participated in a study by researchers ... study results were reported as a poster presentation at ... American College of Sports Medicine in San Diego last ...
Cached Medicine News:Health News:Gene-Altered Foods -Still Not Sure 2Health News:Sports-Formulated Jelly Beans Just as Effective as Sports Drinks 2
(Date:9/2/2015)... Sept. 2, 2015 Boston Scientific Corporation (NYSE: ... Stanley Global Healthcare Conference on September 17, in ... , chief executive officer, and Dan Brennan , executive ... 30-minute question and answer session regarding the company with the ... A live webcast of the question and answer session will ...
(Date:9/2/2015)... , Sept. 2, 2015  RegeneRx Biopharmaceuticals, ... clinical-stage drug development company focused on tissue protection, ... Finkelstein , President and Chief Executive Officer, will ... Renshaw Global Investment Conference, sponsored by H.C. ... held September 8-10, 2015 at the St. Regis ...
(Date:9/2/2015)... -- China Biologic Products, Inc. (NASDAQ: CBPO, "China ... plasma-based biopharmaceutical company in China ... Taibang Biological Products Co., Ltd. ("Guizhou Taibang") entered ... Xinjiang Deyuan Bioengineering Co., Ltd. ("Xinjiang Deyuan") to ... to source no less than 500 tonnes of ...
Breaking Medicine Technology:Boston Scientific To Participate In 2015 Morgan Stanley Global Healthcare Conference 2RegeneRx to Present at Rodman & Renshaw Global Investment Conference 2RegeneRx to Present at Rodman & Renshaw Global Investment Conference 3China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 2China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 3China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 4China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 5
... 31 Eli Lilly and Company announced today that ... GEMZAR(R) (gemcitabine HCl for injection) to the current standard ... survival at three years for women with locally advanced ... most commonly diagnosed women,s cancer, and the second most ...
... III ZODIAC study in advanced non-small cell lung cancer ... at the American Society of Clinical Oncology (ASCO) meeting ... primary endpoint, demonstrating that the addition of vandetanib to ... survival (PFS), the length of time a patient lives ...
Cached Medicine Technology:Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 2Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 3Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 4Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 5Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 6Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology 2Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology 3Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology 4Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology 5
... Activins are polypeptide hormones which ... (TGF-) superfamily. The TGF- superfamily is ... factors which control many aspects of ... (1). Other members incude TGF-s, bone ...
... polypeptide hormones which belong to the ... TGF- superfamily is a large group ... many aspects of development, reproductive function ... incude TGF-s, bone morphogenetic proteins, growth ...
... known as bone Gla protein, is a ... a major component of the noncollagenous bone ... in bone, with a small amount produced ... [1]. During bone formation, newly synthesized osteocalcin ...
... Protein-1 (IGFBP-1) is a phosphoprotein, produced primarily ... modulates the bioactivity of IGF-I and IGF-II ... been completely defined, but the nature of ... involved in glucose regulation and IGF-mediated substrate ...
Medicine Products: